COMBIVIR
- Product NDC
- 49702-202
- 11-digit product format
- 497020202
- Labeler code
- 49702
- Product ID
- 49702-202_42a6587e-9322-4810-8c72-1dc40f3543d2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lamivudine and zidovudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- ViiV Healthcare Company
- Application
- NDA020857
- Marketing category
- NDA
- Marketing start
- 2010-10-19
- Marketing end
- 2027-02-28
- Substance
- LAMIVUDINE; ZIDOVUDINE
- Active strength
- 150; 300 mg/1; mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- COMBIVIR
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LAMIVUDINE | 150 mg/1 |
| ZIDOVUDINE | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2T8Q726O95, 4B9XT59T7S |
| Rxcui | 200082, 213088 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 49702-202-18 | COMBIVIR | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 22 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| LAMIVUDINE | ACTIVE INGREDIENT | 2T8Q726O95 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 10 | |
| ZIDOVUDINE | ACTIVE INGREDIENT | 4B9XT59T7S | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 10 | |
| LAMIVUDINE | ACTIVE MOIETY | 2T8Q726O95 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 10 | |
| ZIDOVUDINE | ACTIVE MOIETY | 4B9XT59T7S | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 10 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 10 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 10 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 10 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 10 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 10 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 10 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 10 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 10 | |
| LAMIVUDINE | ACTIVE INGREDIENT | 2T8Q726O95 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| LAMIVUDINE | ACTIVE INGREDIENT | 2T8Q726O95 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| ZIDOVUDINE | ACTIVE INGREDIENT | 4B9XT59T7S | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| ZIDOVUDINE | ACTIVE INGREDIENT | 4B9XT59T7S | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| LAMIVUDINE | ACTIVE MOIETY | 2T8Q726O95 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| LAMIVUDINE | ACTIVE MOIETY | 2T8Q726O95 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| ZIDOVUDINE | ACTIVE MOIETY | 4B9XT59T7S | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| ZIDOVUDINE | ACTIVE MOIETY | 4B9XT59T7S | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| POLYETHYLENE GLYCOL | INACTIVE INGREDIENT | 3WJQ0SDW1A | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 49702-202 | COMBIVIR (LAMIVUDINE AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 22 | Current NDC, Legacy NDC, 1 package rows | 20241003_16da660b-9981-4d24-a14a-94c7744fce4f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 49702-202-18 | 49702020218 | 60 TABLET, FILM COATED in 1 BOTTLE (49702-202-18) | 2010-10-19 | 2027-02-28 | No | No | Current |